Early Options - A Provider's Guide to Medical Abortion Early Options - A Provider's Guide to Medical Abortion Early Options - A Provider's Guide to Medical Abortion
Home
Information About the Early Options Program
CME Information
Women's Experiences: Video Clips
Video Help
Back to prochoice.org
National Abortion Federation
Module 4 The Role of Ultrasound, hCG Assays, and Clinical Assessment in Medical Abortion - Post-Module Test

We strongly urge you to print out these CME Post-Test Questions before starting this module to help guide you through the material. You will have the opportunity to answer the questions on-line at the end of each module.

1. Transabdominal and transvaginal ultrasound differ in all of the following features except:
  A. View of the pelvic organs
  B. Invasiveness
  C. Difficulty of learning how to perform the procedure
  D. Gestational age at which pregnancy can be detected

2. For transabdominal ultrasound, the discriminatory level is:
  A. 800 mIU/mL
  B. 360 mIU/mL
  C. 2,000 mIU/mL
  D. 3,600 mIU/mL

3. On ultrasound, a true gestational sac is characterized by:
  A. A "double-ring" sign
  B. An echolucent fluid collection without a "double-ring" sign
  C. An echogenic layer of tissue lining the uterine cavity
  D. A "grape-like" sonographic image

4. Which of the following formulas can be used for estimating gestational age:
  A. Mean sac diameter (mm) + 42 ± 3 days
  B. Embryonic length (mm) + 42 ± 3 days
  C. Mean sac diameter (mm) + 30 ± 7 days
  D. Embryonic length (mm) + 30 ± 3 days

5. Which of the following statements about the use of ultrasonography in medical abortion practice is true:
  A. Every patient who undergoes a medical abortion must have a pelvic ultrasound prior to the procedure.
  B. Every patient who undergoes a medical abortion must have a pelvic ultrasound to confirm the outcome of the procedure.
  C. Ultrasonography should be available in medical abortion practice, but it is not required for every patient.
  D. Exposure to high-frequency sound waves poses a significant risk to the health of the woman.

Click here to return to Module 4 - The Role of Ultrasound, hCG Assays, and Clinical Assessment in Medical Abortion

©2009 Copyright National Abortion Federation
Disclaimer | Contact Us